Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole injection for acute upper gastrointestinal bleeding due to peptic ulcer
CTR20132452Phase 2Active
- Sponsor
- Jincheng Haisi Pharmaceutical
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lansoprazole in Peptic ulcer disease (PUD), upper gastrointestinal bleeding (UGIB), sponsored by Jincheng Haisi Pharmaceutical. Started Feb 2016; status: active.
02
Drugs
lansoprazole
03
Conditions
Peptic ulcer disease (PUD)upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on CTR20132452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132452.